Skip to main content
. 2017 Jul 12;8(45):79722–79730. doi: 10.18632/oncotarget.19178

Figure 3. ROC curves for systemic inflammatory response markers in patients with HCC according to MVI-positive (NLR, neutrophil-tolymphocyte ratio; PLR, platelet-to-lymphocyte ratio; ROC, receiver operating characteristic).

Figure 3